These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29476657)

  • 1. Medawar's "actively acquired tolerance" and the Danger model: Setting the record straight.
    Al-Yassin G
    Scand J Immunol; 2018 Sep; 88(3):e12652. PubMed ID: 29476657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medawar's legacy to cellular immunology and clinical transplantation: a commentary on Billingham, Brent and Medawar (1956) 'Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance'.
    Simpson E
    Philos Trans R Soc Lond B Biol Sci; 2015 Apr; 370(1666):. PubMed ID: 25750245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medawar and Hamilton on the selective forces in the evolution of ageing.
    Giaimo S
    Hist Philos Life Sci; 2021 Nov; 43(4):124. PubMed ID: 34822012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adaptation model of immunity: Is the goal of central tolerance to eliminate defective T cells or self-reactive T cells?
    Manjili MH
    Scand J Immunol; 2022 Oct; 96(4):e13209. PubMed ID: 36239215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pattern recognition in peripheral B cell tolerance: lessons from age-associated B cells.
    Johnson JL; Scholz JL; Marshak-Rothstein A; Cancro MP
    Curr Opin Immunol; 2019 Dec; 61():33-38. PubMed ID: 31446338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the Danger model shed any light on central tolerance?: A response to Al-Yassin.
    Fuchs EJ; Matzinger P
    Scand J Immunol; 2018 Sep; 88(3):e12660. PubMed ID: 29542175
    [No Abstract]   [Full Text] [Related]  

  • 7. On Medawar's 'Actively acquired tolerance of foreign cells'.
    Tolar J; Tolarova S; McGrath JA
    Exp Dermatol; 2014 Feb; 23(2):97-8. PubMed ID: 24476006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation tolerance--a historical introduction.
    Brent L
    Immunology; 2016 Mar; 147(3):267-8. PubMed ID: 26694700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medawar's Paradox and Immune Mechanisms of Fetomaternal Tolerance.
    Rendell V; Bath NM; Brennan TV
    OBM Transplant; 2020; 4(1):. PubMed ID: 32582882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune regulator and self-tolerance - molecular and clinical aspects.
    Abramson J; Husebye ES
    Immunol Rev; 2016 May; 271(1):127-40. PubMed ID: 27088911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-myeloablative transplantation of bone marrow expressing self-antigen establishes peripheral tolerance and completely prevents autoimmunity in mice.
    Hosseini H; Oh DY; Chan ST; Chen XT; Nasa Z; Yagita H; Alderuccio F; Toh BH; Chan J
    Gene Ther; 2012 Nov; 19(11):1075-84. PubMed ID: 22071968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations.
    Capalbo D; Giardino G; Martino LD; Palamaro L; Romano R; Gallo V; Cirillo E; Salerno M; Pignata C
    Int Rev Immunol; 2012 Oct; 31(5):344-62. PubMed ID: 23083345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of peripheral tolerance to islet antigens.
    Hamilton-Williams EE; Bergot AS; Reeves PL; Steptoe RJ
    J Autoimmun; 2016 Aug; 72():118-25. PubMed ID: 27255733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On certain two-signal perspectives of lymphocyte activation and inactivation, thymic G-quadruplexes, and the role of aggregation in self/not-self discrimination.
    Forsdyke DR
    Scand J Immunol; 2019 Oct; 90(4):e12797. PubMed ID: 31166602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Questions of Stochasticity and Control in Immune Repertoires.
    Yaari G; Flajnik M; Hershberg U
    Trends Immunol; 2018 Nov; 39(11):859-861. PubMed ID: 30243818
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of immune systems from self/not self to danger to artificial immune systems (AIS).
    Cooper EL
    Phys Life Rev; 2010 Mar; 7(1):55-78. PubMed ID: 20374928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The danger model in deciphering autoimmunity.
    Tveita AA
    Rheumatology (Oxford); 2010 Apr; 49(4):632-9. PubMed ID: 20144928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'The shape of the human being as a function of time': time, transplantation, and tolerance in Peter Brian Medawar's research, 1937-1956.
    Park HW
    Endeavour; 2010 Sep; 34(3):112-21. PubMed ID: 20692038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The curious case of the 1960 Nobel Prize to Burnet and Medawar.
    Silverstein AM
    Immunology; 2016 Mar; 147(3):269-74. PubMed ID: 26790994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The real "danger" lies in the failure to confront fundamentals.
    Cohn M
    Scand J Immunol; 2018 Dec; 88(6):e12726. PubMed ID: 30311672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.